Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05716295
Title A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors (ORCHID-1)
Acronym ORCHID-1
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Medikine, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota Florida 34232 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
NEXT Oncology Austin Austin Texas 78758 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field